 |
SmallCap Network Stock Research
|
|
| Small Cap Biotech Analysis |
The clouds of darkness that have been hanging over CytRx Corporation (NASDAQ:CYTR), may soon be cast aside. The stock, which has traded as low as $.24 earlier this year, appears to be on the rebound with at least two key developments on the horizon.
Here's a closer look at the incredible trading activity for the two stocks we issued alerts on this week: Power3 Medical (OTC:PWRM) and Viking Systems (OTC:VKNG). Are the runs up done or is the table set for yet another push upwards?
Could PWRM easily become the next "Vermillion Dollar Baby?"
You can't go much further down than this. It looks like it's time to go higher from here.
Does this promising penny still have more room to run? You bet!
It's rare to find a profitable small cap biotech company, much less one that has been flying under the radar screen and has so many positive features that can help propel its share price upward quickly.
Some of the names on the list are small caps, but all of the companies are either biotechnology or pharmaceutical and they all meet other Index eligibility criteria.
Accusations are heating up in the drama involving Hemispherx Biopharma, Inc (AMEX:HEB) and the law firms trying to go after the well capitalized company on behalf of investors.
Is the management at CEL-SCI Corporation (AMEX:CVM) signaling that something big is in the works?
The results of a soon to be released study by Bioelectronics Corp. (OTC:BIEL) have set the table for an intriguing penny play in the coming days.
